Modelled lung deposition and retention of welding fume particles in occupational scenarios: a comparison to doses used in vitro.


Journal

Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615

Informations de publication

Date de publication:
04 2022
Historique:
received: 16 12 2021
accepted: 02 02 2022
pubmed: 22 2 2022
medline: 12 4 2022
entrez: 21 2 2022
Statut: ppublish

Résumé

Translating particle dose from in vitro systems to relevant human exposure remains a major challenge for the use of in vitro studies in assessing occupational hazard and risk of particle exposure. This study aimed to model the lung deposition and retention of welding fume particles following occupational scenarios and subsequently compare the lung doses to those used in vitro. We reviewed published welding fume concentrations and size distributions to identify input values simulating real-life exposure scenarios in the multiple path particle dosimetry (MPPD) model. The majority of the particles were reported to be below 0.1 μm and mass concentrations ranged between 0.05 and 45 mg/m

Identifiants

pubmed: 35188583
doi: 10.1007/s00204-022-03247-9
pii: 10.1007/s00204-022-03247-9
pmc: PMC8921161
doi:

Substances chimiques

Air Pollutants, Occupational 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

969-985

Subventions

Organisme : Svenska Forskningsrådet Formas
ID : 2017-00883
Organisme : VINNOVA
ID : 2018-03336

Informations de copyright

© 2022. The Author(s).

Références

Ann Occup Hyg. 2016 Oct;60(8):960-8
pubmed: 27390355
Part Fibre Toxicol. 2010 Nov 03;7:32
pubmed: 21047424
J Toxicol Environ Health A. 1999 Nov 26;58(6):343-63
pubmed: 10580758
Fundam Appl Toxicol. 1995 Nov;28(1):41-50
pubmed: 8566482
Neurotoxicology. 2017 Jan;58:226-237
pubmed: 27989617
Toxicology. 2015 Jun 5;332:30-40
pubmed: 23978460
Toxicol Lett. 2020 Sep 1;329:47-55
pubmed: 32380127
Scand J Work Environ Health. 1978 Jun;4(2):122-30
pubmed: 684387
Ann Occup Hyg. 2012 Jul;56(5):557-67
pubmed: 22539559
J Aerosol Sci. 2016 Sep;99:40-45
pubmed: 27721518
Toxicol Appl Pharmacol. 2018 Dec 15;361:27-35
pubmed: 29738812
Environ Int. 2020 Apr;137:105505
pubmed: 32014789
Ann Occup Hyg. 2016 Mar;60(2):205-19
pubmed: 26464505
J Immunotoxicol. 2012 Oct-Dec;9(4):411-25
pubmed: 22734811
Int Arch Occup Environ Health. 2014 Aug;87(6):623-34
pubmed: 23979145
J Environ Monit. 2012 Feb;14(2):375-82
pubmed: 22037834
J Appl Physiol (1985). 2003 May;94(5):1719-25
pubmed: 12533493
Inhal Toxicol. 2010 Aug;22(10):805-16
pubmed: 20560776
J Occup Environ Hyg. 2019 Jun;16(6):410-421
pubmed: 31084474
Part Fibre Toxicol. 2017 Dec 8;14(1):52
pubmed: 29216928
Ind Health. 2018 Jun 1;56(3):198-206
pubmed: 29237994
Ind Health. 2015;53(1):78-84
pubmed: 25327301
Arch Toxicol. 2017 Aug;91(8):2953-2962
pubmed: 28054104
Arch Toxicol. 2021 Sep;95(9):2961-2975
pubmed: 34287684
Toxicol Sci. 2006 Jul;92(1):126-32
pubmed: 16597657
J Aerosol Med Pulm Drug Deliv. 2020 Oct;33(5):239-248
pubmed: 32758048
J Aerosol Med. 2006 Spring;19(1):74-83
pubmed: 16551218
J Hazard Mater. 2021 Jul 5;413:125273
pubmed: 33581669
Ind Health. 2018 Jul 27;56(4):356-363
pubmed: 29628454
Cancer Res. 1994 May 1;54(9):2342-6
pubmed: 8162579
Sci Rep. 2016 Sep 19;6:33515
pubmed: 27641436
Ann Occup Hyg. 2013 Apr;57(3):305-13
pubmed: 23028013
Toxicol Sci. 2007 Feb;95(2):300-12
pubmed: 17098817
Toxicol Appl Pharmacol. 2004 Apr 1;196(1):95-107
pubmed: 15050411
Toxicol Ind Health. 2020 Dec;36(12):995-1001
pubmed: 33025859
Nanotoxicology. 2019 Dec;13(10):1293-1309
pubmed: 31418618
Environ Health Perspect. 2011 Nov;119(11):1539-46
pubmed: 21788197
J Occup Environ Hyg. 2014;11(1):D1-9
pubmed: 24283338
Environ Sci Process Impacts. 2019 Mar 20;21(3):497-505
pubmed: 30788473
Int J Environ Res Public Health. 2020 Apr 08;17(7):
pubmed: 32276440
Adv Exp Med Biol. 2015;834:1-13
pubmed: 25315619
Ann ICRP. 1994;24(1-3):1-482
pubmed: 7726471
Nanotoxicology. 2017 Aug;11(6):725-736
pubmed: 28660804
Arch Toxicol. 2011 May;85(5):487-98
pubmed: 20924559
Part Fibre Toxicol. 2018 Jun 4;15(1):25
pubmed: 29866184
Scand J Work Environ Health. 2022 Jan 1;48(1):1-3
pubmed: 34821369
Environ Health Perspect. 2005 Jul;113(7):823-39
pubmed: 16002369
Mol Cell Biochem. 2005 Nov;279(1-2):17-23
pubmed: 16283511
Bull Math Biol. 1980;42(3):461-80
pubmed: 7378614
Weld J. 2016 Aug;95(Suppl):280s-285s
pubmed: 27559198
Crit Rev Toxicol. 2003;33(1):61-103
pubmed: 12585507
Ann Occup Hyg. 1978;21(4):363-73
pubmed: 757844
Int J Pharm. 2008 May 22;356(1-2):239-47
pubmed: 18358652

Auteurs

Sarah McCarrick (S)

Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden. sarah.mccarrick@ki.se.

Hanna L Karlsson (HL)

Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.

Ulrika Carlander (U)

Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH